BC Platforms appoints Richard Kivel as Chairman

Richard Kivel

BC Platforms, a specialist in genomic data management and analytics, announces the appointment of Richard Kivel as its Chairman. Richard has extensive expertise in building scientifically driven companies that seek to positively impact human lives, with a focus on creating shareholder value through increasing revenues and bottom-line growth.

Richard has served as a C-level executive, investor and Board Director in both private and public companies in the biotech, bioinformatics and diagnostics space in US, Europe and Asia.

In these roles he was instrumental in establishing a strategic vision and commercial strategy, leading to rapid revenue growth and shareholder value.

Richard is currently the Managing Director at Graybella Capital, a European investment fund and holds various Director positions in the US and Europe. He is also a guest lecturer at the Massachusetts Institute of Technologies (MIT) and Trustee of the Bankinter Foundation of Innovation, a global technology Think-Tank based in Spain & Portugal.

Richard Kivel, commented on his appointment, “I am excited to join as BC Platform’s Chairman. The company has a pioneering technology that has the potential to directly benefit patients through providing more effective clinical decision making and ultimately more personalised medicines. I have been impressed by its management team and commercial strategy and I look forward to supporting them in their growth plans, particularly in the US market.”

Companies